FDA Advances Electronic Submissions for Medical Device PMAs
The U.S. Food and Drug Administration (FDA) is taking another significant step toward modernizing the way medical device companies prepare and submit Premarket Approval Applications…
The U.S. Food and Drug Administration (FDA) is taking another significant step toward modernizing the way medical device companies prepare and submit Premarket Approval Applications…
AI Enters Cosmetic Safety and Adverse-Event Monitoring: From Reactive Reporting to Predictive Cosmetovigilance The cosmetics industry is entering a new phase of safety management. As…
Cell and gene therapy (CGT) has moved from being primarily an experimental frontier to an increasingly established therapeutic modality. The scientific question is no longer…
Industry: Pharmaceuticals | Biotechnology | Regulatory Intelligence | Drug Development The U.S. Food and Drug Administration (FDA) has taken another significant step toward modernizing nonclinical…
A New Milestone for Rare Disease Treatment The U.S. Food and Drug Administration (FDA) has approved FAYUVI (rebisufligene etisparvovec-hopf), developed by Ultragenyx Pharmaceutical, for pediatric…
The pharmaceutical industry is entering a period in which regulatory strategy may increasingly influence not only compliance but also the speed and economics of innovation.…
Biotechnology has traditionally been evaluated through the lens of individual products: a novel therapy, a breakthrough diagnostic, a proprietary enzyme, or a differentiated biological ingredient.…
Precision fermentation is rapidly evolving from a food technology into a broader industrial biotechnology platform. Once primarily associated with alternative proteins, dairy proteins, and functional…
India is increasingly moving beyond its traditional role as a large automotive consumer market and emerging as an important manufacturing, engineering, and export base for…
